Published in Hepatitis Weekly, February 12th, 2007
"Also, the optimal therapy is undefined although several approaches have been made. To evaluate the efficacy and safety of anti-viral therapy (interferon or lamivudine)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.